Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf your Mounjaro pen has been exposed to freezing temperatures, there are physical signs you can check before injecting: the liquid inside may look cloudy, contain visible particles, or the plunger may feel unusually stiff. A frozen or previously frozen pen should not be used. Mounjaro (tirzepatide) must be stored between 2°C and 8°C in the refrigerator — never in the freezer compartment, and never left where it could freeze, such as against the back wall of the fridge or in an unheated car boot in winter. These are prescription-only medicines dispensed after clinical assessment, so if you have any doubt about whether your pen has been compromised, the right call is to contact your prescriber or pharmacy before injecting.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The solution inside an intact Mounjaro KwikPen is clear and essentially colourless. That is the baseline. When a pen has frozen (even partially, even briefly) the liquid may no longer look the same once it thaws. You might notice cloudiness or a milky appearance where the solution was once transparent. There may be visible particles or clumps suspended in the liquid. In some cases the pen mechanism itself may feel wrong: the plunger stiffer than usual, or the dose window obscured.
The difficulty is that freezing damage is not always obvious. A pen that looks clear after thawing may still have undergone protein degradation that you cannot see. That is the core reason the instruction exists: when in doubt, do not inject. The NHS medicines page for tirzepatide and the Patient Information Leaflet that comes with every pen both give clear storage guidance, the leaflet is the definitive reference for your specific product.
Check the pen in good light, hold it at eye level, and look through the viewing window. If anything looks off (colour, clarity, floating material) treat it as compromised. The same applies if you simply cannot be certain the pen was never frozen. There is no reliable way to reverse freezing damage, and no visual test that guarantees the medicine is still effective.
Mounjaro pens freeze most often in predictable situations. A pen left too close to the freezer compartment inside the fridge, particularly against the back wall, can reach sub-zero temperatures without the fridge alarm triggering. Pens ordered over a long weekend or a bank holiday sometimes sit in a delivery vehicle or a cold porch for longer than intended, worth thinking about if you are planning a Monday order around a school holiday or a long weekend when DPD routes may be slower than usual.
Travel is another common culprit: a pen packed in hold luggage on a flight, stored in a car boot in January, or left on a windowsill overnight in a cold house. The risk period is not just the storage temperature but the duration. A brief dip below freezing is less certain to cause visible changes than an extended freeze.
Understanding what your pen has been through matters because tirzepatide is a biological medicine. Its structure depends on precise formulation conditions. Once that structure is disrupted by freezing, the medicine cannot be relied on to work correctly, and injecting a degraded solution carries its own risks. If you are also curious about what frozen tirzepatide looks like and how the damage occurs at a molecular level, our dedicated page goes into more detail on the science behind cold-chain failure. You can read more about how tirzepatide works and what affects its stability on our tirzepatide overview page.
If you are managing multiple pens at different dose strengths, keep a simple log of when each pen came out of the fridge, it removes the guesswork on the room-temperature window question too.
This is the question most people are actually trying to answer, and the honest answer is: if there is any reasonable doubt, replace the pen and contact your prescriber or pharmacy. The cost and inconvenience of a replacement pen is far smaller than the cost of injecting a compromised medicine, either in terms of ineffective treatment or unknown safety risk.
The practical decision tree is short. If the solution looks clear and colourless, the pen has been stored correctly and consistently, and you are confident it was never frozen: proceed as normal. If the solution is cloudy, discoloured, or contains particles: do not use it. If you are not sure whether the pen froze, perhaps it arrived after a delayed delivery, or you found it in an unusual location: do not use it.
Getting a replacement through a regulated route is straightforward. Patients using Mounjaro through a private prescriber should contact their pharmacy directly. At nume, our prescribers are available for aftercare queries seven days a week, if your pen has been compromised and you need clinical guidance on next steps, our support team can connect you with a prescriber quickly. Questions about injection technique and confirming that a dose has gone in correctly are covered in more detail on our page about checking whether your Mounjaro injection was successful.
For a broader picture of what affects your pen (from temperature to injection sites to what happens at different points in a treatment course) our Mounjaro treatment guide covers the practical questions our prescribers hear most often.
If you received a pen that appears to have frozen in transit, that is a cold-chain failure worth reporting. For medicines dispensed by a GPhC-registered pharmacy, contact the pharmacy first. You can also report a suspected product quality issue directly to the MHRA via the Yellow Card scheme, the same system used for reporting side effects. The MHRA takes cold-chain failures seriously, particularly for biological medicines.
Cold-chain failure is also one of the risk factors associated with counterfeit or illegally traded weight-loss pens. Pens bought outside the licensed UK supply chain (from social media sellers or unverified websites operating without a valid prescription process) have no guarantee of correct storage at any point in their journey. The MHRA has seized large quantities of fake pens in recent years, some of which were found to contain substances other than the stated medicine. If you have ever wondered how to tell if someone is on Mounjaro, including the physical and behavioural signs that are commonly noticed, our guide walks through what the research and clinical experience suggest. Buying from a pharmacy you can verify on the GPhC register is the clearest protection against that risk.
If you are weighing up your options for Mounjaro treatment more broadly, including what a clinically supervised private service looks like, our Mounjaro cost guide sets out what to look for beyond the headline price. When you are ready, you can speak to our prescribers through a free consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.